Welcome New VALIDATE Members
We are very pleased to welcome 14 new members to the growing VALIDATE Community. We are always happy to welcome new members, so please let your colleagues know about the benefits of membership and how to join.
Associates
Affiliates
- Dr Marcia Ashmi, ICAR-Indian Veterinary Research Institute, India
- Miss Alberta Ateere, University of Oxford, UK
- Ms Silvia Calvo García, University of Zaragoza, Spain
- Dr Joconiah Chirenda, University of Zimbabwe, Zimbabwe
- Dr Deb Dutta, National Institute of Mental Health and Neuro Sciences (NIMHANS), India
- Dr Tim Fredsgaard-Jones, University of Oxford, UK
- Ms Claudia Guerrero Perales, University of Zaragoza, Spain
- Dr Meera Madhavan, University of Oxford, UK
- Dr Elton Rogozi, Institute of Public Health Albania, Albania
- Dr Hiroyuki Saiga, NIID, Japan
- Ms Himani Tripathi, CURAJ, India
- Mr Sujeet Singh, Central University of Rajasthan, India
- Mrs Lindsey Waddell, Roslin Institute, UK
Seminar Today - A Vaccine for Melioidosis? - 13:00 BST
Today, Prof Mukhopadhyay and Dr Dastidar will discuss the prospects for a vaccine for Melioidosis, the disease caused by a bacterium, Burkholderia pseudomallei, which is found across tropical and semi-tropical regions worldwide and causes up to 89,000 deaths a year. If you want to join the seminar, email Blakeley - blakeley.nixon@ndm.ox.ac.uk.
Funding:
- MCR Biomedical Catalyst 2022 - Supporting the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “re-purposing” of existing therapies - deadline: 25 May 2022
- Knowledge Transfer Partnerships (KTP) - Knowledge Transfer Partnerships (KTPs) accelerate business innovation by supporting knowledge exchange with academic institutions - deadline 15 June 2022
- Innovate UK Smart Grants, 2022 -Opportunity for UK registered organisations to apply for a share of up to £25 million from Innovate UK to deliver disruptive R&D innovations that can significantly impact the UK economy - deadline 27 July 2022
You can find a list of all relevant external funding we've spotted for our members on our external funding page.
- Human infection studies: Key considerations for challenge agent development and production, Balasingam S et al, in Welcome Open Research
- Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccines, Pelzer P et al, in PLOS Public Health
- Global epidemiology of leprosy from 2010 to 2020: A systematic review and meta-analysis of the proportion of sex, Yang J et al, in Pathogens and Global Health
- Defining the Role of Cellular Immune Signatures in Diagnostic Evaluation of Suspected Tuberculosis, Halliday A et al, in The Journal of Infectious Disease
- Whole-genome sequencing of Mycobacterium tuberculosis from Cambodia, Edokimov K et al, in Nature Scientific Reports
- T cell transcription factor expression evolves over time in granulomas from Mycobacterium tuberculosis-infected cynomolgus macaques, Grant NL et al, in Cell Reports
- Identification of Immunodominant Antigens From the First-Generation Vaccine Against Cutaneous Leishmaniasis, Germano J et al, in Frontiers in Immunology
- Non-volatile organic compounds in exhaled breath particles correspond to active tuberculosis, Chen D et al, in Nature Scientific Reports
Published: 18 May 2022
